Clinical Trial

Chemoablation for Low-Grade Bladder Cancer

Name: Chemoablation for Low-Grade Bladder Cancer — clinical trial record (NCT07019220)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: COBRA

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this single arm, prospective, open-label, investigator-initiated Phase 2 clinical trial is to evaluate the efficacy of intravesical chemoablation in patients with low grade bladder cancer.

Trial Details

NCT Number	NCT07019220
Lead Sponsor	Ekaterina Laukhtina
Conditions	Bladder (Urothelial, Transitional Cell) Cancer
Enrollment	47 participants
Start Date	2023-12-27
Primary Completion	2027-11 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2025-06-13